MXPA06005679A - Formas cristalinas de clorhidrato de 3-beta-amino, 17-metilen, androstan-6-alfa, 7-beta-diol. - Google Patents

Formas cristalinas de clorhidrato de 3-beta-amino, 17-metilen, androstan-6-alfa, 7-beta-diol.

Info

Publication number
MXPA06005679A
MXPA06005679A MXPA06005679A MXPA06005679A MXPA06005679A MX PA06005679 A MXPA06005679 A MX PA06005679A MX PA06005679 A MXPA06005679 A MX PA06005679A MX PA06005679 A MXPA06005679 A MX PA06005679A MX PA06005679 A MXPA06005679 A MX PA06005679A
Authority
MX
Mexico
Prior art keywords
beta
alpha
methylene
androstan
amino
Prior art date
Application number
MXPA06005679A
Other languages
English (en)
Spanish (es)
Inventor
Marc-Antoine Perrin
Original Assignee
Inflazyme Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0312257A external-priority patent/FR2861077B1/fr
Application filed by Inflazyme Pharm Ltd filed Critical Inflazyme Pharm Ltd
Publication of MXPA06005679A publication Critical patent/MXPA06005679A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA06005679A 2003-10-20 2004-10-20 Formas cristalinas de clorhidrato de 3-beta-amino, 17-metilen, androstan-6-alfa, 7-beta-diol. MXPA06005679A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51267903P 2003-10-20 2003-10-20
FR0312257A FR2861077B1 (fr) 2003-10-20 2003-10-20 Formes cristallines du chlorydrate de 3-beta-amino, 17-methylene, androstane-6-alpha, 7-beta-diol
PCT/IB2004/003426 WO2005037851A1 (fr) 2003-10-20 2004-10-20 Formes cristallines du chlorhydrate de 3-beta-amino, 17-methylene, androstane-6-alpha, 7-beta-diol

Publications (1)

Publication Number Publication Date
MXPA06005679A true MXPA06005679A (es) 2006-08-17

Family

ID=34466415

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06005679A MXPA06005679A (es) 2003-10-20 2004-10-20 Formas cristalinas de clorhidrato de 3-beta-amino, 17-metilen, androstan-6-alfa, 7-beta-diol.

Country Status (8)

Country Link
EP (1) EP1680441A1 (ko)
JP (1) JP2007509050A (ko)
KR (1) KR20070007766A (ko)
AU (1) AU2004281998A1 (ko)
CA (1) CA2542821A1 (ko)
MX (1) MXPA06005679A (ko)
RU (1) RU2006117320A (ko)
WO (1) WO2005037851A1 (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK15692002A3 (sk) * 2000-04-28 2003-11-04 Inflazyme Pharmaceuticals Limited 3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie

Also Published As

Publication number Publication date
WO2005037851A1 (fr) 2005-04-28
AU2004281998A1 (en) 2005-04-28
KR20070007766A (ko) 2007-01-16
JP2007509050A (ja) 2007-04-12
EP1680441A1 (fr) 2006-07-19
CA2542821A1 (fr) 2005-04-28
RU2006117320A (ru) 2007-11-27

Similar Documents

Publication Publication Date Title
EP3174891B1 (en) Crystalline form of nicotinamide riboside
EP2773620B1 (en) Ivabradine hydrochloride form iv
CA2350956C (en) New crystals of celecoxib
EP3022209B1 (en) Dolutegravir potassium salt
EP3433233B1 (en) Novel crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine salt
EP3205653A1 (en) Crystal form of bisulfate of jak inhibitor and preparation method therefor
EP3243824A1 (en) Solid forms of ibrutinib free base
EP2247570B1 (en) Novel salts of o-desmethyl-venlafaxine
EP3426675B1 (en) Crystalline salt forms
JP2004528336A (ja) アジスロマイシン水和物の１，２−プロピレングリコール包接化合物、その製造方法およびそれを含む医薬組成物
EA019689B1 (ru) Бензолсульфонат 2-[[[2-[(гидроксиацетил)амино]-4-пиридинил]метил]тио]-n-[4-(трифторметокси)фенил]-3-пиридинкарбоксамида, его кристаллы, его полиморфы и способы их получения
WO2011101862A1 (en) Stabilized fluconazole polymorph iii formulation
US11866420B2 (en) Hydrochloride salt forms of a sulfonamide structured kinase inhibitor
EP1311506A2 (en) Chiral fluoroquinolizinone arginine salt forms
MXPA06005679A (es) Formas cristalinas de clorhidrato de 3-beta-amino, 17-metilen, androstan-6-alfa, 7-beta-diol.
PL194752B1 (pl) Krystaliczna postać VI 5,6-dichloro-2-(izopropyloamino)-1-(ß-L-rybofuranozylo)-1H-benzimidazolu, sposób jej wytwarzania, kompozycja farmaceutyczna zawierająca krystaliczną postać i zastosowanie krystalicznej postaci
CN116514775A (zh) 一种徳拉沙星葡甲胺盐新晶型及其制备方法
EP1264821B1 (en) Novel crystal of stilbene derivative and process for producing the same
CN106279017A (zh) 贝达喹啉晶型、组合物及其制备方法
US20080051382A1 (en) Crystalline Forms of 3-Beta-Amino 17-Methylene Androstane-6-Alpha 7-Beta-Diol Hydrochloride
WO2019099761A1 (en) Solid state forms of elafibranor
EP1944297A1 (en) Solid and crystalline rimonabant and processes for preparation, and pharmaceutical composition thereof
EP1363882A1 (en) 3-(3-amidinophenyl)-5- ( 1-(1-(-iminoethyl)-4-piperidyl amino)methyl]benzoic acid dihydrochloride and process for preparing the same
US20240140966A1 (en) Amorphous and crystalline forms of mcl-1 antagonists
WO2004050647A2 (en) Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof